Confocal Endomicroscopy of Pancreatic InVivo

Status Completed

Clinical Trial Summary

Confocal laser endomicroscopy (CLE) is a novel and highly promising imaging method for that allows in vivo imaging of the mucosal layer at resolution of approximately 1 micron. Cellular and sub-cellular structures as well as capillaries and single red blood cells can be visualized. CLE is now well established as a highly accurate method for distinguishing neoplasia in the gastrointestinal tract lumen via endoscopy. A major new breakthrough is the development of sub-millimeter CLE probes that can be passed via an image guided needle (nCLE) into solid organs and cysts.

It is hypothesized that nCLE will help distinguish the benign, premalignant and malignant cystic lesions of pancreas by visualizing the cellular lining of the cysts, thereby, avoiding unnecessary surgery in patient with benign cysts and guiding to early and effective surgical removal of high risk neoplastic lesions.

A prototype minimal risk nCLE system has been developed that can be passed via standard endoscopic ultrasound needles into the pancreas but FDA clearance for in vivo use is not expected until late 2010. The investigators propose to evaluate this prototype nCLE system in vivo during endoscopic ultrasound (EUS), as an initial pilot study.

Clinical Trial Description

Hypothesis: the confocal laser endomicroscopy imaging of the nCLE can differentiate between non-mucinous, mucinous non- malignant and malignant pancreatic cysts in vivo and has increased sensitivity compared to endoscopic ultrasound-fine needle aspiration (EUS-FNA) tissue sampling. In this pilot study the investigators will primarily evaluate technical feasibility and interobserver agreement.

1. In patients undergoing EUS for suspected pancreatic cysts, the investigators will evaluate the key nCLE image features of non mucinous, mucinous, and malignant pancreatic cystic neoplasms (PCN).

2. The investigators will estimate the initial image quality, feasibility, and interobserver agreement of nCLE

3. The investigators will establish the preliminary accuracy of nCLE to be used for planning a larger comparative trial ;

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01035008
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	December 2009
Completion date	November 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01624363` - Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound	N/A
Completed	`NCT01447238` - Diagnosis of Pancreatic Cysts: Endoscopic Ultrasound With Fine Needle Aspiration (EUS/FNA), Direct Visualization, and Confocal Laser-induced Endomicroscopy-A Pilot Study
Completed	`NCT01202136` - The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study
Completed	`NCT01698710` - Endoscopic Abraxane Injection Into Pancreatic Cysts	N/A
Recruiting	`NCT02110498` - Early Detection of Pancreatic Cystic Neoplasms
Completed	`NCT00828048` - International Registry for Intraductal Papillary Mucinous Neoplasma
Terminated	`NCT02494388` - Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions	N/A
Terminated	`NCT01769534` - Registry and Fluid Banking of Pancreatic Cystic Lesions	N/A
Recruiting	`NCT04400357` - Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors	N/A
Completed	`NCT01236300` - In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors	N/A
Completed	`NCT01929460` - A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration	N/A
Completed	`NCT01883336` - Long Term Follow up of Small Non-inflammatory Pancreatic Cysts
Completed	`NCT01392027` - Biospecimens for Identification of Diseases of the Pancreas.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.